Health Execs, physicians and diplomats were awed by the new medical devices presented by three Taiwanese companies that will enhance surgeon skills, accurately detect thyroid cancer and relieve patient bed sores. “Taiwan Medical Marvels” was the theme of this international press conference and products launch held at the Orange County Convention Center in Orlando during the Florida International Medical Expo (FIME), one of the …

Augmenix K.K. announces that SpaceOAR hydrogel, a soft, implanted absorbable gel spacer is now available to all prostate cancer radiotherapy patients in Japan through the Ministry of Health, Labour & Welfare (MHLW) national reimbursement. SpaceOAR hydrogel is clinically proven to assist in the decrease of unwanted side effects from radiotherapy treatment in patients with prostate cancer. Stephen J. McGill, Vice …

Orthofix International N.V. announced the U.S. Food and Drug Administration (FDA) 510(k) clearance for its new internal fixation system, the G-Beam™ Fusion Beaming System. Designed primarily for the treatment of Charcot foot, a debilitating condition where the bones in the foot weaken and collapse, the G-Beam devices can be implanted in the medial and lateral columns of the foot to …

Cellular Biomedicine Group Inc., a leading clinical-stage biopharmaceutical firm engaged in the development of immunotherapies for cancer, has announced its plan to configure part of its facility in Shanghai with GE Healthcare’s FlexFactory platform, which will be designed to speed up manufacturing timelines for its cell therapy clinical trials and commercial launch. There are more than 900 regenerative medicine trials …

Cellular Biomedicine Group Inc. has announced its plan to configure part of its facility in Shanghai with GE Healthcare’s FlexFactory™ platform, which will be designed to speed up manufacturing timelines for its cell therapy clinical trials and commercial launch. There are more than 900 regenerative medicine trials underway globally, including trials in cell and gene therapy, a 19 percent increase …

Cardiovascular Systems, Inc. announced two new partnerships broadening the company’s product portfolio. CSI is now the exclusive U.S. distributor of OrbusNeich balloon products. Additionally, the company has signed an original equipment manufacturer (OEM) agreement with Integer Holdings Corporation for CSI-branded ZILIENT™ guidewires. Scott Ward, CSI’s Chairman, President and Chief Executive Officer, said, “We intend to build on our market-leading position …

Fullerton Healthcare Corporation Limited (Fullerton Health) announced that it has entered into agreements to acquire a 60% stake in the Intellicare Group, one of the leading managed care providers in the Philippines. The Philippines is an important market in Asia Pacific for Fullerton Health, underpinned by attractive underlying growth drivers. Completion of the transaction is subject to the fulfilment of …

LivaNova PLC and MicroPort Scientific Corporation announced that the companies have entered into a binding Letter of Intent (“LOI”) for the sale of LivaNova’s Cardiac Rhythm Management (“CRM”) Business Franchise to MicroPort for $190 million in cash. The CRM Business Franchise develops, manufactures and markets products for the diagnosis, treatment and management of heart rhythm disorders and heart failures. CRM …

Teijin Nakashima Medical Co. announced that it has agreed to acquire the orthopedic business, principally spine fixation devices and spine cages of Century Medical, Inc. Opening a new window, an importer and distributer of medical devices in Japan. The sale will be completed in early January 2018. Teijin has been expanding its commercial involvement with implantable medical devices, including by …

Genomic Vision announced that it has signed an exclusive distribution agreement with AmCare Genomics Laboratory to market the FSHD diagnostic assay in China. “We are thrilled to have acquired Genomic Vision’s technology and signed an exclusive distribution agreement for the FSHD diagnostic assay in China. Thanks to our large network and connections within the neurology and FSHD communities in China, …